Access to medicines
Public Health Ethics 1 (2):73-82 (2008)
| Abstract | Professor Thomas Pogge, Professorial Fellow, Centre for Applied Philosophy, LPO Box 8260, Canberra. Tel.: +61 261255485; Email: tp6{at}columbia.edu ' + u + '@' + d + ' '//--> Abstract I would pay three million to go into space, says the banker to his attorney. — I wouldn't go if you paid me, the latter laughs, for me the French Riviera is quite exciting enough. Ah, I would pay a million for an extra year of life , the elderly tourist effusively tells his lover. — We have never had even a hundred dollars , the Cambodian teenager replies, we are a large family. CiteULike Connotea Del.icio.us What's this? | |||||||||
| Keywords | No keywords specified (fix it) | |||||||||
| Categories | ||||||||||
| Options |
|
|||||||||
Download options| PhilPapers Archive |
Upload a copy of this paper Check publisher's policy on self-archival Papers currently archived: 5,701 |
| External links |
 |
| Through your library | Configure |
Similar books and articlesThomas Pogge (2006). Montréal Statement on the Human Right to Essential Medicines. Cambridge Quarterly of Healthcare Ethics 16 (01).
Ville Päivänsalo (2009). Responsibilities for Global Health: The Efficiency of the Health Impact Fund? Public Health Ethics 2 (1).
Matthew Lee & Jillian Kohler (forthcoming). Benchmarking and Transparency: Incentives for the Pharmaceutical Industry's Corporate Social Responsibility. Journal of Business Ethics.
Michael Ravvin (2008). Incentivizing Access and Innovation for Essential Medicines: A Survey of the Problem and Proposed Solutions. Public Health Ethics 1 (2):110-123.
Matthew Rimmer (2008). Race Against Time: The Export of Essential Medicines to Rwanda. Public Health Ethics 1 (2):89-103.
Klaus M. Leisinger (2009). Corporate Responsibilities for Access to Medicines. Journal of Business Ethics 85:3 - 23.
N. Craig Smith & Anne Duncan (2005). GlaxoSmithKline and Access to Essential Medicines (B). Journal of Business Ethics Education 2 (1):123-132.
Devi Sridhar (2008). Improving Access to Essential Medicines: How Health Concerns Can Be Prioritised in the Global Governance System. Public Health Ethics 1 (2):83-88.
Michael J. Selgelid (2008). A Full-Pull Program for the Provision of Pharmaceuticals: Practical Issues. Public Health Ethics 1 (2):134-145.
Analytics
Monthly downloads |
Added to index2009-12-21Total downloads13 ( #87,971 of 549,122 )Recent downloads (6 months)1 ( #63,361 of 549,122 )How can I increase my downloads? |
My notes
Discussion
